Invirsa

Natural small molecule indicated for acute conjunctivitis of viral origin

placeColumbus, Ohio, United States calendar_todayFounded 2014 groups3 employees language invirsa.com

Innovation

4 patent families (2 granted) — focus: Human necessities; filing pace steady. Cited 761 times.

YearFilings
20171
20181
20191
20201
20212
20221
20232
20241
20253
20261

Investor mix

5 investors on record; lead investors include Rev1 Ventures, CincyTech.

Investor typeCountShare
Venture capital360%
Accelerator & incubator120%
Other / undisclosed120%
Coming soon